222 related articles for article (PubMed ID: 32375872)
1. The cholinergic system in subtypes of Alzheimer's disease: an in vivo longitudinal MRI study.
Machado A; Ferreira D; Grothe MJ; Eyjolfsdottir H; Almqvist PM; Cavallin L; Lind G; Linderoth B; Seiger Å; Teipel S; Wahlberg LU; Wahlund LO; Westman E; Eriksdotter M;
Alzheimers Res Ther; 2020 May; 12(1):51. PubMed ID: 32375872
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.
Eyjolfsdottir H; Eriksdotter M; Linderoth B; Lind G; Juliusson B; Kusk P; Almkvist O; Andreasen N; Blennow K; Ferreira D; Westman E; Nennesmo I; Karami A; Darreh-Shori T; Kadir A; Nordberg A; Sundström E; Wahlund LO; Wall A; Wiberg M; Winblad B; Seiger Å; Wahlberg L; Almqvist P
Alzheimers Res Ther; 2016 Jul; 8(1):30. PubMed ID: 27389402
[TBL] [Abstract][Full Text] [Related]
3. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
[TBL] [Abstract][Full Text] [Related]
4. MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.
Teipel S; Grothe MJ;
Neurobiol Dis; 2023 May; 180():106070. PubMed ID: 36898615
[TBL] [Abstract][Full Text] [Related]
5. Antemortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology.
Teipel SJ; Grothe MJ;
Eur J Neurol; 2022 May; 29(5):1394-1401. PubMed ID: 35122358
[TBL] [Abstract][Full Text] [Related]
6. Differential response to donepezil in MRI subtypes of mild cognitive impairment.
Diaz-Galvan P; Lorenzon G; Mohanty R; Mårtensson G; Cavedo E; Lista S; Vergallo A; Kantarci K; Hampel H; Dubois B; Grothe MJ; Ferreira D; Westman E
Alzheimers Res Ther; 2023 Jun; 15(1):117. PubMed ID: 37353809
[TBL] [Abstract][Full Text] [Related]
7. Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor.
Ferreira D; Westman E; Eyjolfsdottir H; Almqvist P; Lind G; Linderoth B; Seiger A; Blennow K; Karami A; Darreh-Shori T; Wiberg M; Simmons A; Wahlund LO; Wahlberg L; Eriksdotter M
J Alzheimers Dis; 2015; 43(3):1059-72. PubMed ID: 25147108
[TBL] [Abstract][Full Text] [Related]
8. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
Mohanty R; Ferreira D; Frerich S; Muehlboeck JS; Grothe MJ; Westman E;
Neurology; 2022 Jul; 99(4):e323-e333. PubMed ID: 35609990
[TBL] [Abstract][Full Text] [Related]
9. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
[TBL] [Abstract][Full Text] [Related]
10. Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.
Ossenkoppele R; Lyoo CH; Sudre CH; van Westen D; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Westman E; Tsai R; Kramer J; Boxer AL; Gorno-Tempini ML; La Joie R; Miller BL; Rabinovici GD; Hansson O
Alzheimers Dement; 2020 Feb; 16(2):335-344. PubMed ID: 31672482
[TBL] [Abstract][Full Text] [Related]
11. MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis.
Persson K; Eldholm RS; Barca ML; Cavallin L; Ferreira D; Knapskog AB; Selbæk G; Brækhus A; Saltvedt I; Westman E; Engedal K
PLoS One; 2017; 12(10):e0186595. PubMed ID: 29036183
[TBL] [Abstract][Full Text] [Related]
12. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia.
Grothe MJ; Schuster C; Bauer F; Heinsen H; Prudlo J; Teipel SJ
J Neurol; 2014 Oct; 261(10):1939-48. PubMed ID: 25059393
[TBL] [Abstract][Full Text] [Related]
13. Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.
Grothe M; Heinsen H; Teipel SJ
Biol Psychiatry; 2012 May; 71(9):805-13. PubMed ID: 21816388
[TBL] [Abstract][Full Text] [Related]
14. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
Teipel S; Grothe MJ;
J Alzheimers Dis; 2016 Apr; 52(4):1443-51. PubMed ID: 27079707
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal Atrophy Subtypes of Alzheimer's Disease Using Automatic MRI in a Memory Clinic Cohort: Clinical Implications.
Persson K; Edwin TH; Knapskog AB; Tangen GG; Selbæk G; Engedal K
Dement Geriatr Cogn Disord; 2022; 51(1):80-89. PubMed ID: 35344967
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.
Teipel S; Heinsen H; Amaro E; Grinberg LT; Krause B; Grothe M;
Neurobiol Aging; 2014 Mar; 35(3):482-91. PubMed ID: 24176625
[TBL] [Abstract][Full Text] [Related]
17. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes.
Boon BDC; Labuzan SA; Peng Z; Matchett BJ; Kouri N; Hinkle KM; Lachner C; Ross OA; Ertekin-Taner N; Carter RE; Ferman TJ; Duara R; Dickson DW; Graff-Radford NR; Murray ME
Neurology; 2023 Oct; 101(14):e1412-e1423. PubMed ID: 37580158
[TBL] [Abstract][Full Text] [Related]
18. A Review of Brain Atrophy Subtypes Definition and Analysis for Alzheimer's Disease Heterogeneity Studies.
Zhang B; Lin L; Wu S
J Alzheimers Dis; 2021; 80(4):1339-1352. PubMed ID: 33682711
[TBL] [Abstract][Full Text] [Related]
19. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
[TBL] [Abstract][Full Text] [Related]
20. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]